Bindra, Jas
Chopra, Ishveen
Hayes, Kyle
Niewoehner, John
Panaccio, Mary
Elliott, Sheila
Trawick, Bobby
Wan, George J. https://orcid.org/0000-0002-1140-740X
Funding for this research was provided by:
Mallinckrodt Pharmaceuticals
Article History
Received: 1 April 2025
Accepted: 30 April 2025
First Online: 22 May 2025
Declarations
:
: Kyle Hayes, John Niewoehner, Sheila Elliott, Bobby Trawick, and George J. Wan are employees of Mallinckrodt Pharmaceuticals and declare that they have no other conflicts of interest. Ishveen Chopra, Jas Bindra, and Mary Panaccio are paid research consultants for the study and declare that they have no other conflicts of interest.
: An independent ethics committee (WCG IRB, Princeton, New Jersey, USA) reviewed and approved the study protocol, consent form, and survey tool. The ethics committee also granted an exemption from the requirements of federal regulation 45 CFR 46.101(b)(2) and certified this exemption status (#1-1781602-1) on July 9, 2024. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. Prior to participating in this online survey, all participants were presented with an information page outlining the study’s purpose, procedures, and their right to withdraw at any time. By proceeding with the survey, participants indicated their informed consent to participate and for the use of their anonymized and aggregated responses for presentations and publication. This process was documented electronically.